Page last updated: 2024-08-23

du-21220 and cefotetan

du-21220 has been researched along with cefotetan in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (33.33)	18.2507
2000's	2 (66.67)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL	1
Lombardo, F; Obach, RS; Waters, NJ	1
Curto, C; Sbracia, M; Scarpellini, F; Scarpellini, L	1

Trials

1 trial(s) available for du-21220 and cefotetan

Article	Year
Effectiveness of a cephalosporin, cefotetan, in inhibition of uterine matrix metalloproteinases by a non-antibacterial mechanism. Annals of the New York Academy of Sciences, 1994, Sep-06, Volume: 732 Topics: alpha 1-Antitrypsin; Biomarkers; CA-125 Antigen; Cefotetan; Female; Fetal Membranes, Premature Rupture; Fibronectins; Glycosaminoglycans; Humans; Hydroxyproline; Metalloendopeptidases; Pregnancy; Pregnancy Trimester, Second; Ritodrine; Uterus	1994

Article

Year

Effectiveness of a cephalosporin, cefotetan, in inhibition of uterine matrix metalloproteinases by a non-antibacterial mechanism.

Annals of the New York Academy of Sciences, 1994, Sep-06, Volume: 732

Topics: alpha 1-Antitrypsin; Biomarkers; CA-125 Antigen; Cefotetan; Female; Fetal Membranes, Premature Rupture; Fibronectins; Glycosaminoglycans; Humans; Hydroxyproline; Metalloendopeptidases; Pregnancy; Pregnancy Trimester, Second; Ritodrine; Uterus

1994

Other Studies

2 other study(ies) available for du-21220 and cefotetan

Article	Year
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling. Current drug discovery technologies, 2004, Volume: 1, Issue:4 Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration	2004
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7 Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding	2008

Article

Year

Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.

Current drug discovery technologies, 2004, Volume: 1, Issue:4

Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration

2004

Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.

Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008